Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis

ConclusionIncidence of seroconversion in MS patients who had been treated with natalizumab is higher in European/American countries than Asian countries.
Source: Journal of Clinical Neuroscience - Category: Neuroscience Source Type: research